Long-term potassium-competitive acid blockers administration causes microbiota changes in rats-Reference-Cited by-同舟云学术

Long-term potassium-competitive acid blockers administration causes microbiota changes in rats

Published:2023-07-14 Issue:10 Volume:37 Page:7980-7990
ISSN:0930-2794
Container-title:Surgical Endoscopy
language:en
Short-container-title:Surg Endosc

Author:

Najah Haythem^ORCID,Edelmuth Rodrigo C. L.,Riascos Maria Cristina,Grier Alex,Al Asadi Hala,Greenberg Jacques A.,Miranda Ileana,Crawford Carl V.,Finnerty Brendan M.,Fahey Thomas J.,Zarnegar Rasa

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00464-023-10269-6.pdf

Reference40 articles.

1. Sachs G, Shin JM, Vagin O, Lambrecht N, Yakubov I, Munson K (2007) The gastric H, K atpase as a drug target: past, present, and future. J Clin Gastroenterol 41:S226–S242. https://doi.org/10.1097/MCG.0b013e31803233b7

2. Chey WD, Mody RR, Izat E (2010) Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement? Dig Dis Sci 55:3415–3422. https://doi.org/10.1007/s10620-010-1209-2

3. Luo H-J, Deng W-Q, Zou K (2014) Protonated form: the potent form of potassium-competitive acid blockers. PLoS ONE 9:97688. https://doi.org/10.1371/journal.pone.0097688

4. Sachs G, Shin JM, Hunt R (2010) Novel approaches to inhibition of gastric acid secretion. Curr Gastroenterol Rep 12:437–447. https://doi.org/10.1007/s11894-010-0149-5

5. Shin JM, Inatomi N, Munson K, Strugatsky D, Tokhtaeva E, Vagin O, Sachs G (2011) Characterization of a novel potassium-competitive acid blocker of the Gastric H, K-ATPase, 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1 H-pyrrol-3-yl]-N-ethylmethanamine monofumarate (TAK-438). J Pharmacol Exp Ther 339:412–420. https://doi.org/10.1124/jpet.111.185314